café-au-lait macules
Conditions
Interventions
Experimental group:In the initial stage, combined multi-laser therapy with P755 nm, P532 nm, Q755 nm and Q532 nm is administered. The optimal laser is then selected base
Sponsors
Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients with untreated café-au-lait macules; 2.Aged >=1 month; 3.Patients or their guardians fully understand the treatment regimen and related risks, voluntarily sign the informed consent form, and agree to receive treatment and complete follow-up.
Exclusion criteria
Exclusion criteria: 1.Patients with other diseases associated with café-au-lait macules; 2.Patients with active infection, abscess or ulcer at the treatment site; 3.Patients allergic to local anesthetics; 4.Pregnant or lactating women; 5.Patients participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Subjective Visual Assessment Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Trends in pigmentation improvement during treatment and follow-ups (1 month, 3 months);Differences in treatment responses under different lesion characteristics (such as size, color, and edge shape);The occurrence and recovery of treatment-related side effects; | — |
Countries
China
Contacts
Public ContactLin Xiaoxi
Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Outcome results
None listed